Your browser doesn't support javascript.
International registry of dermatological manifestations secondary to COVID-19 infection in 347 Hispanic patients from 25 countries.
Ocampo-Candiani, Jorge; Ramos-Cavazos, Cesar Jair; Arellano-Mendoza, Maria Ivonne; Arenas-Guzmán, Roberto; Beirana-Palencia, Angélica; Salmon-Demongin, Alfredo; Welsh-Hernández, Esperanza; Cabo, Horacio A; Gómez-Flores, Minerva; Dominguez-Cherit, Judith; Criado, Paulo Ricardo; Castro-López, Helena; Alfaro-Sánchez, Abraham Benjamin; García-Vargas, Alejandro; Cohen-Sabban, Emilia N; Del Solar, Manuel; Fich, Félix; Galimberti, Gastón; Gatti, Carlos Fernando; López-Estebaranz, José Luis; Lupi, Omar; Olmos-Pérez, Miguel; Pérez-Alfonzo, Ricardo.
  • Ocampo-Candiani J; Universidad Autónoma de Nuevo León, Servicio de Dermatología, Hospital Universitario "Dr. José E. González", Monterrey, México.
  • Ramos-Cavazos CJ; Universidad Autónoma de Nuevo León, Servicio de Dermatología, Hospital Universitario "Dr. José E. González", Monterrey, México.
  • Arellano-Mendoza MI; Departamento de Dermatología, Hospital General de México, Ciudad de México, México.
  • Arenas-Guzmán R; Hospital "Manuel Gea González", Secretaría de Salud, Ciudad de México, México.
  • Beirana-Palencia A; Sociedad Mexicana de Dermatología, Ciudad de México, México.
  • Salmon-Demongin A; Departamento editorial Latin American Journal of Clinical Sciences and Medical Technology, Ciudad de México, México.
  • Welsh-Hernández E; Academia Mexicana de Dermatología, Monterrey, México.
  • Cabo HA; Departamento de Dermatología, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Gómez-Flores M; Universidad Autónoma de Nuevo León, Servicio de Dermatología, Hospital Universitario "Dr. José E. González", Monterrey, México.
  • Dominguez-Cherit J; Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" Ciudad de México, México.
  • Criado PR; Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil.
  • Castro-López H; Hospital General Regional No. 2. El Marqués, IMSS, Querétaro, México.
  • Alfaro-Sánchez AB; Academia Mexicana de Dermatología, Monterrey, México.
  • García-Vargas A; Hospital de la Heroica Escuela Naval, Ignacio Zaragoza, Veracruz Llave, Mexico.
  • Cohen-Sabban EN; Servicio de Dermatología, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Buenos Aires, Argentina.
  • Del Solar M; Servicio de Dermatología, Hospital Cayetano Heredia, Facultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Perú.
  • Fich F; Departamento de Dermatología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Galimberti G; Sección de Oncología Cutánea y Cirugía de Mohs, Hospital italiano, Buenos Aires, Argentina.
  • Gatti CF; Instituto de Medicina Cutánea de Buenos Aires, Buenos Aires, Argentina.
  • López-Estebaranz JL; Servicio de Dermatología, Hospital Universitario Fundación Alcorcón, Madrid, España.
  • Lupi O; Universidade Federal do Rio de Janeiro (UFRJ), Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Policlínica Geral do Rio de Janeiro (PGRJ), Rio de Janeiro, Brazil.
  • Olmos-Pérez M; Departamento de Dermatología, Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia.
  • Pérez-Alfonzo R; Departamento de Dermatología, Instituto de Biomedicina, Universidad Central de Venezuela, Hospital Vargas Clínica El Ávila, Caracas, Venezuela.
Int J Dermatol ; 60(8): 956-963, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1219767
ABSTRACT

BACKGROUND:

The infection by coronavirus disease 2019 (COVID-19) has been associated with multiple cutaneous manifestations, although characterization of them in Hispanic patients with darker skin phototypes is lacking. The objective of this study is to characterize the clinical dermatological manifestations associated with COVID-19 infection in cases with few or without general symptoms in patients from Latin America.

METHODS:

Cross-sectional study using a questionnaire that was made for health professionals (physicians with a specialty in dermatology) to investigate dermatological lesions associated with COVID-19 infection in patients from 25 countries of Latin America. The survey was active from June 9 to July 30, 2020.

RESULTS:

In this study, information was collected from a total of 347 patients. We found a female gender predominance 179/347 (51.6%). The mean age at presentation was 40.87 years. The most frequent dermatological manifestations were maculopapular rash and urticarial lesions, followed by papulovesicular lesions, vesicular lesions, chilblain-like lesions, papular lesions, ecchymosis, petechial purpura, pityriasis rosea-like lesions, pruritus, palmoplantar dysesthesias, transient livedo, acral necrosis, palpable purpura, livedo racemosa, and retiform purpura. As far as we know, there are no previous reports of pruritus and palmoplantar dysesthesias.

CONCLUSIONS:

This registry emphasizes skin manifestations as an important criterion for establishing the diagnosis of COVID-19 infection in Latin American countries. This information will be useful for the early identification of suspected cases by health professionals (dermatologists and nondermatologists) and will allow contact tracing to mitigate the impact on health systems at different levels.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans Language: English Journal: Int J Dermatol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans Language: English Journal: Int J Dermatol Year: 2021 Document Type: Article